Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,206 | 6,206 | 4,772 | 3,149 | 2,951 |
| Marketable Securities | 9,725 | 15,427 | 17,264 | 29,381 | 41,667 |
| Receivables | 1,160 | 212 | 52 | 80 | 247 |
| Other current assets | 0 | 0 | 0 | 580 | 0 |
| TOTAL | $16,878 | $22,322 | $22,861 | $34,135 | $46,380 |
| Non-Current Assets | |||||
| PPE Net | 104 | 165 | 116 | 132 | 7 |
| Investments And Advances | 0 | 0 | 0 | 0 | 2,022 |
| Other Non-Current Assets | 24 | 24 | 24 | 3,276 | 4,074 |
| TOTAL | $128 | $189 | $140 | $3,408 | $6,103 |
| Total Assets | $17,006 | $22,511 | $23,001 | $37,543 | $52,482 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 2,311 |
| Accounts payable and accrued liabilities | 972 | 272 | 1,396 | 600 | 2,289 |
| Accrued Expenses | 1,236 | 921 | 1,219 | 1,078 | 1,017 |
| Other current liabilities | N/A | N/A | 17 | N/A | N/A |
| TOTAL | $2,528 | $1,513 | $2,632 | $1,678 | $5,617 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 320 | 320 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 0 | 0 | 0 | 230 | 1,296 |
| TOTAL | $N/A | $N/A | $N/A | $230 | $1,296 |
| Total Liabilities | $2,528 | $1,513 | $2,632 | $1,908 | $6,912 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,300 | 5,350 | 5,316 | 5,204 | 5,191 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -209,396 | -199,769 | -199,777 | -183,425 | -172,666 |
| Other shareholders' equity | -36 | -32 | -34 | -61 | -59 |
| TOTAL | $14,477 | $20,998 | $20,369 | $35,635 | $45,570 |
| Total Liabilities And Equity | $17,006 | $22,511 | $23,001 | $37,543 | $52,482 |